Archive note: this May 2026 article is kept for historical context. For live status, use the current shortages dashboard. The live official data now shows 21 active shortage rows; some May items below have since resolved or changed status.
Key Shortages This Month
Ramipril โ SSP Extended
The Serious Shortage Protocol for Ramipril 1.25mg capsules and 2.5mg tablets remains active. Pharmacists can continue to supply alternative strengths and quantities without a new prescription. If you take ramipril, speak to your pharmacist before your supply runs low.
Propranolol MR Capsules
Supply of propranolol 80mg and 160mg modified-release capsules remains constrained. The DHSC Medicine Supply Notification is ongoing. Immediate-release propranolol tablets are generally available as an alternative for many patients โ discuss with your GP before switching formulations.
Creon (Pancreatic Enzymes)
Both Creon 10000 and 25000 capsules remain under active Serious Shortage Protocols. These are critical for patients with cystic fibrosis, chronic pancreatitis, and pancreatic cancer. Pharmacists can supply reduced quantities under SSP โ no prescription charge applies for SSP-supplied Creon.
HRT โ Estradiol Products
In the May snapshot, multiple estradiol products were affected. The current live HRT data shows active Estradot SSP rows, while Oestrogel and Sandrena are historic records rather than current official active rows. If your specific HRT product is unavailable, ask your pharmacist about equivalent alternatives and check the live status page first.
Fluoxetine
Several fluoxetine strengths were listed in the May snapshot. The latest official MediWatch data does not show a current active fluoxetine shortage row. Check the fluoxetine page for current status before acting on archive information.
ADHD Medications
Elvanse (lisdexamfetamine) supply had improved compared with the 2024 disruption. The latest official MediWatch data does not show current active Elvanse or methylphenidate shortage rows, though local pharmacy availability can still vary.
Insulin & GLP-1
Multiple insulin products continue to face supply pressure, including Fiasp, Humalog vials, and Levemir. The global GLP-1 shortage (Ozempic, Wegovy, Mounjaro) continues with demand outpacing manufacturing capacity. NHS England maintains strict prescribing restrictions for weight-management GLP-1 use.
What to Do If Your Medication Is Short
- Don't wait until you're out. Order repeat prescriptions as early as your GP surgery allows โ ideally 2 weeks before you need them.
- Try multiple pharmacies. Shortages are often regional. A pharmacy a few miles away may have stock when your local one doesn't.
- Ask about alternatives. For many shortages, pharmacists can supply an equivalent medicine under a Serious Shortage Protocol without you needing a new prescription.
- Sign up for alerts. Get free MediWatch alerts for your specific medications and be notified the moment supply status changes.
Get Alerts for Your Medications
MediWatch tracks current official shortage rows across hundreds of medicines. Sign up free and get notified when your prescription is affected.
Start Monitoring FreeSources: DHSC Medicine Supply Notifications, NHSBSA Serious Shortage Protocols, Community Pharmacy England. Article snapshot accurate as of 12 May 2026; live-status notes added 13 June 2026.